HIPK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.318800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.273600E-01
Normal-vs-Stage2
6.726800E-01
Normal-vs-Stage3
1.740300E-02
Normal-vs-Stage4
1.396600E-01
Stage1-vs-Stage2
9.603600E-01
Stage1-vs-Stage3
4.138300E-02
Stage1-vs-Stage4
4.217800E-02
Stage2-vs-Stage3
9.806300E-02
Stage2-vs-Stage4
4.938000E-02
Stage3-vs-Stage4
1.176540E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.670800E-01
Normal-vs-AfricanAmerican
8.105200E-01
Normal-vs-Asian
6.879600E-01
Caucasian-vs-AfricanAmerican
1.827820E-01
Caucasian-vs-Asian
8.807000E-01
AfricanAmerican-vs-Asian
4.376600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.428600E-01
Normal-vs-Female
6.278000E-01
Male-vs-Female
9.640400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.335400E-01
Normal-vs-Age(41-60Yrs)
7.675200E-01
Normal-vs-Age(61-80Yrs)
3.684000E-01
Normal-vs-Age(81-100Yrs)
8.227600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.591600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.362200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.502000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.354800E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.344400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.134600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.133800E-01
Normal-vs-Daily Drinker
2.801400E-01
Normal-vs-Weekly Drinker
2.532600E-01
Normal-vs-Occasional Drinker
8.794000E-01
Normal-vs-Social Drinker
8.750000E-01
Non Drinker-vs-Daily Drinker
8.975800E-01
Non Drinker-vs-Weekly Drinker
9.517400E-01
Non Drinker-vs-Occasional Drinker
1.298440E-02
Non Drinker-vs-Social Drinker
8.501900E-02
Daily Drinker-vs-Weekly Drinker
9.605200E-01
Daily Drinker-vs-Occasional Drinker
2.733700E-02
Daily Drinker-vs-Social Drinker
1.212980E-01
Weekly Drinker-vs-Occasional Drinker
4.726500E-02
Weekly Drinker-vs-Social Drinker
1.612980E-01
Occasional Drinker-vs-Social Drinker
5.936000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.141390E-01
Normal-vs-Grade 2
2.559800E-02
Normal-vs-Grade 3
2.569900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.780200E-01
Grade 1-vs-Grade 3
7.505800E-01
Grade 1-vs-Grade 4
1.141390E-01
Grade 2-vs-Grade 3
4.958600E-01
Grade 2-vs-Grade 4
2.559800E-02
Grade 3-vs-Grade 4
2.569900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.410200E-01
Normal-vs-NonDiabetic
5.450000E-01
Diabetic-vs-NonDiabetic
1.882950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.017200E-01
Normal-vs-NoPancreatitis
4.879600E-01
Pancreatitis-vs-NoPancreatitis
9.651000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.020200E-01
Normal-vs-N1
7.045800E-01
N0-vs-N1
2.658000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.782600E-01
Normal-vs-TP53-NonMutant
7.806200E-01
TP53-Mutant-vs-TP53-NonMutant
6.897600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
